Trandolapril-d3

• Description:

  Trandolapril-d3 is the deuterium labeled Trandolapril (HY-B0592) . Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI) [1].

• UNSPSC:

  12352005

• Target:

  Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled Compounds

• Related Pathways:

  Metabolic Enzyme/Protease; Others

• Field of Research:

  Cardiovascular Disease

• Smiles:

  [H][C@@](CCCC1)(N2C([C@@H](N[C@H](CCC3=CC=CC=C3)C(OCC)=O)C([2H])([2H])[2H])=O)[C@]1(C[C@H]2C(O)=O)[H]

• Molecular Formula:

  C24H31D3N2O5

• Molecular Weight:

  433.56

• References & Citations:

  [1]Peters DC, et al. Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders. Drugs. 1998 Nov;56 (5) :871-93.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported